← Back to directory

Georg Schett

Researcher Next ID · RN-023472

Researcher · Medicine

Karolinska University Hospital

Stockholm, Germany

Not currently recruitingFunding unknown
Works count
1,702
Citation count
101,697
H-index
156
i10-index
885

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Rheumatoid Arthritis Research and Therapies
Spondyloarthritis Studies and Treatments
Bone Metabolism and Diseases
Systemic Sclerosis and Related Diseases
Systemic Lupus Erythematosus Research

Publications

  • CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

    New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2308917

  • Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

    Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-02017-5

  • CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus

    New England Journal of Medicine · 2021 · 10.1056/nejmc2107725

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-217159

  • EULAR definition of difficult-to-treat rheumatoid arthritis

    Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-217344

  • Locally renewing resident synovial macrophages provide a protective barrier for the joint

    Nature · 2019 · 10.1038/s41586-019-1471-1

  • Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis

    Nature Reviews Rheumatology · 2018 · 10.1038/s41584-018-0109-2

  • Enthesitis: from pathophysiology to treatment

    Nature Reviews Rheumatology · 2017 · 10.1038/nrrheum.2017.188

  • Trial of Tocilizumab in Giant-Cell Arteritis

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1613849

  • Pathogenetic insights from the treatment of rheumatoid arthritis

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31472-1

  • Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss

    Nature Communications · 2017 · 10.1038/s41467-017-02490-4

  • Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

    Cell Death and Differentiation · 2016 · 10.1038/cdd.2016.11

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

    Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-208337

  • EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

    Annals of the Rheumatic Diseases · 2015 · 10.1136/annrheumdis-2014-206971

  • Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines

    Nature Medicine · 2014 · 10.1038/nm.3547

  • Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

    Nature Communications · 2012 · 10.1038/ncomms1734

  • Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment

    Nature Reviews Rheumatology · 2012 · 10.1038/nrrheum.2012.153

  • Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

    Journal of Clinical Investigation · 2012 · 10.1172/jci60975

  • The Pathogenesis of Rheumatoid Arthritis

    New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmra1004965

  • Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

    Nature · 2010 · 10.1038/nature09387

  • Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

    The Journal of Experimental Medicine · 2008 · 10.1084/jem.20081165

  • Cytokines in the pathogenesis of rheumatoid arthritis

    Nature reviews. Immunology · 2007 · https://doi.org/10.1038/nri2094

  • Dickkopf-1 is a master regulator of joint remodeling

    Nature Medicine · 2007 · 10.1038/nm1538

  • Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease

    Circulation · 2004 · 10.1161/01.cir.0000127957.43874.bb

  • Osteoclasts are essential for TNF-α–mediated joint destruction

    Journal of Clinical Investigation · 2002 · 10.1172/jci15582

Current projects

    No projects listed.